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ABSTRACT 
Alexithymia is a personality trait characterized by a diminished ability to identify and 
describe feelings, as well as an inability to distinguish physical symptoms associated with 
emotional arousal. Alexithymia is elevated in both patients with epilepsy (a 
neurologically-based seizure disorder) and psychogenic nonepileptic seizures (PNES; a 
psychological condition mimicking epilepsy); however, different neuropsychological 
processes may underlie this deficit in the two groups. To expand on previous research 
considering factors contributing to alexithymia in these populations, we examined the 
extent to which scores on the Toronto Alexithymia Scale (TAS-20) were predicted by 
performance on measures of executive and language functioning. We studied 138 PNES 
and 150 epilepsy patients with video-EEG confirmed diagnoses. Neuropsychological 
tests were administered to assess executive functioning (interference scores of the Stroop 
Color-Word Test and Part B of the Trail Making Test) and language functioning 
(Animals, Controlled Oral Word Association Test, and Boston Naming Test). 
Hierarchical linear regressions revealed that the relationships between disparate 
neuropsychological domains and alexithymia were not moderated by diagnosis of PNES 
or epilepsy. Multiple regression analyses within each group demonstrated that phonemic 
verbal fluency and response inhibition were significant predictors of alexithymia in 
epilepsy. Thus, alexithymia may reflect impairments in language and aspects of executive 
functioning in both PNES and epilepsy.  
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1 
Introduction 
Psychogenic nonepileptic seizures (PNES) and epilepsy are both marked by 
complex interactions between vulnerable cognitive and emotional systems that contribute 
to functional impairment. Despite presenting similar cognitive and affective 
vulnerabilities, the pathological mechanisms behind these vulnerabilities are disparate. 
One shared vulnerability is alexithymia, which includes a disturbance in components of 
cognitive and affective processing, and is more common in those with PNES and epilepsy 
than in the general population (Tojek et al., 2000; Myers, Matzner et al., 2013; Wolf et 
al., 2015). Although the Toronto Alexithymia Scale (TAS-20), the most widely used 
measure of alexithymia (Taylor, Parker, Bagby, 1997), has been hypothesized to assess 
the cognitive component of alexithymia (Bermond et al., 2007), less is known about the 
relationships between alexithymia and other neurocognitive deficits, particularly in 
individuals who experience either epileptic seizures or PNES. 
Definitions and Prevalence  
Alexithymia. Alexithymia is a personality construct associated with disrupted 
affective and cognitive functioning. Originally coined by Sifneos (1972), the term 
alexithymia was derived from the Greek translation of “no words for emotions,” and was 
used to explain clinical features seen in patients with psychosomatic disorders who had 
trouble engaging in insight-oriented psychotherapy. Alexithymia is a multi-faceted 
concept that describes a condition characterized by difficulties identifying and describing 
one’s emotions, a lack of introspection (i.e., externally oriented thinking), and difficulties 
distinguishing feelings from physical symptoms associated with emotional arousal 
(Lesser, 1981; Sifneos, 1972). 
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Alexithymia is estimated to affect 10% of the general population (Salminen, 
Saarijärvi, Äärelä, Toikka, & Kauhanen, 1999), and constitutes a major risk factor for a 
range of medical and psychiatric problems, including chronic pain, somatization, anxiety, 
and depression (Taylor & Bagby, 2004). Alexithymia has also been found in those with a 
variety of medical and psychological disorders, including traumatic brain injury, 
Alzheimer’s disease, stroke, autism spectrum disorders, hypertension, eating disorders, 
and schizophrenia (Kauhanen, Kaplan, Cohen, Julkunen, & Salonen, 1996; Luminet & 
Rimé, 2004; Taylor et al., 1997). Research has demonstrated that alexithymia is 
associated with a host of adverse mental and physical health outcomes, as well as 
decreased quality of life, due to its relation to poor emotion regulation capabilities 
(Swart, Kortekaas, & Aleman, 2009), interpersonal problems (Besharat, 2010), and 
stress-related medical conditions (Todarello, Taylor, Parker, & Fanelli, 1995).  
Psychogenic nonepileptic seizures. Psychogenic nonepileptic seizures are 
classified as a type of conversion disorder (a functional neurological symptom disorder) 
in the DSM-5 (APA, 2013), and are characterized by involuntary seizure-like episodes 
occurring in the absence of epileptiform EEG activity. PNES are believed to be in part 
the result of dysregulated affect, and typically are associated with trauma, posttraumatic 
stress disorder, dissociation, somatization, and other comorbid psychopathology (Brown 
& Reuber, 2016).  PNES patients also commonly present with deficits in cognitive 
processes, including spatial working memory, verbal memory, attention, executive 
functioning, language, and executive control processes (for a review, see Wilmet, Hill, 
Baslet, & Loring, 2015). Resting-state fMRI studies support the vulnerable cognitive-
emotional model, by demonstrating alterations in connectivity between emotional, 
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executive control, and sensorimotor networks (van der Kruijs, Bodde, Vaessen, 2012; 
Ding, An, Liao, 2014).  
Epilepsy. Epilepsy is the fourth most common neurological disorder in humans 
and is characterized by recurrent, unprovoked and unpredictable seizures due to abnormal 
excessive or synchronous neuronal activity in the brain (Fisher et al., 2005). Epileptic 
seizures can disrupt multiple aspects of cognition, including processes for working and 
episodic memory, attention, concentration, language, executive functions, emotions, and 
social judgement (Exner et al., 2002; McAndrews & Cohn, 2012; McDonald et al., 2011; 
Meletti & Benuzzi, 2009). Affective processes are also disrupted, with comorbid 
depression, anxiety, and select emotion deficits (e.g., impaired recognition of fear states 
in temporal lobe epilepsy) (Meletti et al., 2009). 
Alexithymia in PNES and epilepsy. Alexithymia is elevated in those with PNES 
and epilepsy, with different studies reporting different rates. Tojek et al. (2000), Myers, 
Matzner et al. (2013), and Wolf et al. (2015) reported that roughly 30% of PNES and 
epilepsy patients fell within the alexithymic range. In contrast, some studies found a 
much higher proportion of individuals scoring in the alexithymic range – up to 90.5% of 
PNES patients and 76.2% of epileptic patients (Bewley et al., 2005) and 63% of epileptic 
patients (Urbanek et al., 2014). Alexithymia in PNES and epilepsy has predominantly 
been studied in regard to its impact on quality of life and facets of mental health, and its 
predictive utility in discriminating between the two diagnostic groups. Underlying 
processes contributing to alexithymia in these groups are less established. 
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Conceptualizing Alexithymia 
Alexithymia is currently conceptualized as a cluster of cognitive traits, 
including: (1) difficulty identifying feelings, differentiating among the range of 
common affects, and distinguishing feelings from physical symptoms connected 
with emotional arousal; (2) difficulty describing feelings; (3) confined imaginal 
processes resulting in the limited ability to fantasize and incorporate imagery; and 
(4) an externally oriented cognitive style, which refers to a specific tendency to 
deal with superficial themes and to avoid affective or introspective thinking 
(Taylor, Bagby, & Parker, 1985 & 1997). Taylor, Bagby, and Parker were the first 
to further delve into the core tenets of alexithymia and stated that alexithymic 
characteristics:  
“…reflect deficits both in the cognitive-experiential domain of emotion 
response system and at the level of interpersonal regulation of emotion. 
[…] Lacking knowledge of their own emotional experiences, alexithymic 
individuals cannot readily imagine themselves in another person’s 
situation and are consequently unempathetic and ineffective in modulating 
the emotional states of others” (Bagby, Taylor, & Parker,1997, pp. 30-31).  
Deficits in affective perception. From a neuropsychological perspective, 
alexithymia can be understood as the insufficient or ineffective cognitive processing and 
regulation of affective information (Taylor et al., 1997; Wingbermuhle et al., 2012). This 
may be the result of disrupted affective arousal in response to external emotional triggers, 
as indicated by reduced activation in limbic and paralimbic structures (e.g., amygdala, 
insula, anterior cingulate cortex (ACC)) (Moriguchi et al., 2013). A fundamental 
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consequence of dysfunctions in this process is a deficit in conscious awareness of 
emotions in alexithymic individuals, which suggests that they possess limited capacity to 
understand how their feelings relate to higher-level affects, cognitions, memories, and 
specific experiences (Taylor et al., 1997). This lack of emotional self-recognition has 
social implications as well, particularly for understanding and expressing the mental 
states of others. Moriguchi et al., (2006) observed that high alexithymic individuals had 
trouble taking the perspective of others and had reduced medial prefrontal cortex 
activation during a Theory of Mind task, indicating that emotional self-awareness seems 
to be closely related to sensitivity to the emotions of other and empathetic ability.  
This study provided additional support for previous findings that have shown 
alexithymia to be inversely related to the ability to accurately recognize and identify 
affective facial expressions (Parker et al., 1993; Lane et al., 1995, 2000; Jongen et al., 
2014), photographs of emotional scenes, and the emotional valence of sentences (Lane et 
al., 1996). In response to pictures of angry facial expressions, people with alexithymia 
showed reduced activation in the dorsal ACC, right anterior insula (Kano et al., 2003), 
and right caudate (Lee et al., 2011). 
Imagery and fantasy. Another important factor associated with alexithymia is 
the limited ability to fantasize and incorporate imagery. Imagery can be defined as the 
manipulation of sensory information that comes from memory without information from 
actual sensory input (Cabeza and Nyberg, 2000). Decreased imaginative involvement and 
an externally oriented thinking style in alexithymia have been consistently documented 
during daydreaming, fantasy, and nocturnal dreams (Lumley & Bazydlo, 2000; Nielsen, 
Levrier, & Montplaisir, 2011; Parker, Bauermann, & Smith, 2000; Vingerhoets, Van 
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Heck, Grim, & Bermond, 1995). This concept was originally included in the factors 
measured by the TAS, (Taylor, Ryan, Bagby, 1985), but was later eliminated because the 
fantasy subscale was not validated as a separate factor (Bagby et al., 1994). In a 
neuroimaging study, Mantani et al., (2005) demonstrated that people with alexithymia 
showed reduced neural activation in the posterior cingulate cortex through various 
conditions during an imagery task (e.g., possible future happy things, past happy things, 
past sad things etc.). The authors therefore suggested that the ability to imagine future 
events by using memories of past emotional events is compromised in individuals with 
alexithymia, whereas non-alexithymic individuals had little trouble with this task. 
Consistent with that finding, a pair of studies found that alexithymic individuals, 
compared to non-alexithymics, were unable to visualize their own emotional states 
(Trajdos-Giejdasz et al., 2004), had poorer (less vivid) imagery, and had less enjoyment 
and involvement during an autogenic relaxation exercise with guided imagery 
(Friedlander, Lumley, Farchione, and Doyal, 1997). In one study, the authors found 
results consistent with the idea that alexithymia related deficits are specific to processing 
emotional arousal (Peasley-Miklus, Panayiotou, Vrana, 2015). Specifically, that 
alexithymia was related to higher heart rate during neutral and lower heart rate during 
fear imagery, which suggests difficulties with parasympathetic control and emotion 
regulation.  
Somatosensory or sensorimotor level stimulus. As previously stated, a 
tremendous amount of research has been conducted on the processing of external 
affective stimuli and self-originating thoughts (i.e., imagery or fantasy) in alexithymia. 
Results found when the experimental design included physical stimulation stand in stark 
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contrast to those studies. For example, previous studies demonstrated that alexithymic 
individuals have a significantly lower threshold for pain when receiving electrical 
stimulation, and the degree of alexithymia correlates with the score of somatosensory 
amplification (Nyklicek and Vingerhoets, 2000; Nakao et al., 2002). To further 
understand how alexithymic individuals respond to visceral stimulation, Kano et al., 
(2007) induced colonic distension by inserting a balloon inflator into the colon of each 
participant; cerebral blood flow was measured during interoceptive stimulation of the 
colon by inflating the balloon. Increased neural activation was found in regions important 
for processing somatosensory information (i.e., pregenual ACC, right insula, and 
midbrain) in alexithymic individuals compared to non-alexithymic individuals. 
Furthermore, alexithymics also reported greater physical symptoms stemming from the 
inflation, such as feeling stress, pain, anxiety, and the urge to defecate. In a less invasive 
study, Moriguchi et al. (2007) examined the neural response of participants as they 
viewed pictures depicting human hands and feet receiving painful stimulation. High 
alexithymic subjects, relative to low alexithymic subjects, had increased activation in the 
affective pain matrix (i.e., somatosensory cortex, insula, and ACC), despite not receiving 
any physical stimulation. Of note, high alexithymic participants also had reduced 
activation in areas involved in executive cognitive functioning, such as the dorsolateral 
prefrontal cortex.  
Overall, these studies indicate that people with high alexithymia scores have 
enhanced primitive somatosensory and sensorimotor-level brain function, which may 
contribute to amplifying physical sensations, such as pain. The results of neuroimaging 
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studies are in line with clinical findings indicating that people with alexithymia tend to 
complain about external physical symptoms rather than reporting internal mental states.  
Neuropsychological Deficits in Alexithymia 
Verbal and language deficits in alexithymia. Extensive research has been 
conducted on the specific characteristics and attributes of alexithymia; less is known 
about how neuropsychological deficits contribute to the manifestation of alexithymia 
characteristics. Lamberty and Holt (1995), and later Henry and colleagues (2006), 
provided evidence that alexithymia is primarily a product of verbal deficits and is related 
to executive dysfunction. These findings were replicated when Woods and Williams 
(2007) found a negative relationship between alexithymia and verbal and sequencing 
abilities. Alexithymia has been linked to lower scores on verbal, non-verbal and general 
intelligence tests (Wiethaeuper and Bakbinotti, 2013). In another study, alexithymia was 
inversely associated with performance on the Controlled Oral Word Association Test 
(COWAT), a measure of phonemic verbal fluency (Paradiso, Vaidya, McCormick, Jones, 
& Robinson, 2008).  
 Executive function deficits in alexithymia. Executive functions are a set of 
complex cognitive processes that enable a person to direct attention, plan strategies, solve 
problems, and modify behaviors in order to achieve future goals (Alvarez, Emory, 2006; 
Salthouse, 2005). In addition to the studies demonstrating the relationship between 
alexithymia and verbal deficits, several studies have shown deficits in a range of other 
neuropsychological domains. According to Zhang (2011), high alexithymic individuals, 
relative to low alexithymic individuals, had significantly greater reaction time on a 
conflict-processing task, suggesting that alexithymic individuals may have less efficient 
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executive control. Alexithymia was found to be negatively correlated with performance 
on the Wisconsin Card Sorting Test (WCST), which assess perseveration and abstract 
thinking (Xiong-Zhao, Xiao-Yan, & Ying, 2006), and low alexithymic individuals had a 
greater number of correct responses and a higher rate of categorization (Zhu, Wang, 
Huang, Yao, & Tang, 2006). Koven & Thomas (2010) noted the relationship of factors 
pertaining to emotional clarity (the ability to identify and understand one’s emotions; 
which consists of aspects of alexithymia, emotional intelligence, and mood awareness), to 
be negatively associated with inhibition, set-shifting, emotional control, self-monitoring, 
task initiation, planning, and task monitoring. 
Current Study 
 Alexithymia is believed to reflect deficits in the cognitive processing of emotions 
(Taylor, Parker, Bagby, 1997). Greater alexithymia has been connected to impaired 
affective processes and cognitive functioning in several neuropsychological domains, 
including verbal abilities (Lamberty & Holt, 1995; Wood & Williams, 2007) and aspects 
of executive functioning (Koven et al., 2010). Given the elevated frequency of 
alexithymia found in PNES and epileptic patients, the present study sought to expand our 
understanding of the cognitive mechanisms involved in the manifestation of alexithymia 
by examining the relationship between alexithymia and neuropsychological functioning.   
 One would expect PNES patients to have significantly higher levels of 
alexithymia (compared to epileptic patients), given that greater levels of psychopathology 
(i.e., depressive, anxiety, somatization disorders) and higher rates of psychological 
trauma have been associated with PNES and alexithymia. Therefore, it was first 
hypothesized (H1) that PNES patients would have higher scores on the Toronto 
10 
Alexithymia Scale, and all of its subscales (i.e., Difficulty Identifying Feelings, Difficulty 
Describing Feelings, and Externally Oriented Thinking) compared to epileptics. Second, 
it was hypothesized that diagnosis would significantly moderate the relationship between 
neuropsychological measures (H2a: verbal/language ability; H2b: executive function) and 
alexithymia. More specifically, it was hypothesized that verbal/language performance 
would be more predictive of alexithymia in epilepsy (H3a), while executive function 
performance would be more predictive of alexithymia in PNES (H3b). 
Method 
Participants  
The sample consisted of 288 participants, 150 of whom were diagnosed with 
epilepsy and 138 diagnosed with PNES. See Table 1 for sample characteristics. 
Participants were patients at the Mayo Clinic Arizona epilepsy monitoring unit (EMU). 
Only individuals who completed the TAS-20 and had a video-EEG confirmed diagnosis 
of either epilepsy or PNES (but not both) were included in this study. There is some 
overlap between this sample and the sample included in Wolf et al., (2015), but the Wolf 
et al. sample included participants not included in this sample, and vice versa.  
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Table 1  
Sample Characteristics 
  Epilepsy (n = 150) PNES (n = 138)  
Variable Mean SD Mean SD pdiff 
Age at Evaluation 39.21 18.11 42.23 13.8 .091 
Gender  51.6% female - 72.1% female - < .001 
Handed 91.3% right - 94.2% right - .323 
Years of Education 13.99 2.42 14.34 3.07 .261 
Employment Status 42.9% yes - 40.3% yes - .64 
Disability 11.2% yes - 27.9% yes - < .001 
Driving 42.2% yes - 40.9% yes - .815 
Age of Onset 27.51 19.83 36.43 15.92 < .001 
Seizure Frequency 18% daily - 34.4% daily - < .001 
Febrile Seizures 5.6% yes - 3.9% yes - .48 
Multiple Seizure Types 49.7% yes - 50.6% yes - .873 
Psych Hx 69.6% yes - 90.9% yes - < .001 
Sex Abuse 4.3% yes - 25.3.% yes - < .001 
Abuse  14.3% yes - 51.9% yes - < .001 
Alexithymia (TAS-20 
scores ≥ 61) 
27.3% yes - 35.1% yes - .136 
Note. pdiff = significance (two-tailed) of the difference in means for each measure. 
Procedure 
Following Institutional Review Board approval, a retrospective review of data 
collected during routine clinical practice at the Mayo Clinic Arizona Epilepsy Monitoring 
Unit (EMU) was performed. It is standard procedure in the EMU for all appropriate 
patients to receive comprehensive neuropsychological evaluation. During this evaluation 
process, demographic information, medical history, and psychosocial information are 
collected. These variables are listed in Table 1. The data used in this study were collected 
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between July 2011 and June 2016, a self-report measure of alexithymia was added to the 
standard neuropsychological battery used in the EMU in July 2011.  
Measures 
 Diagnosis. Patients diagnosed with epilepsy met the following criteria: typical 
events occurred with epileptiform discharges, or, if no typical events occurred, the 
described semiology was concerning for epilepsy; interictal epileptiform discharges were 
seen on EEG; and antiepileptic medication was started at discharge. Those diagnosed 
with PNES met the following criteria: typical events occurred with no epileptiform 
discharges; no interictal epileptiform abnormalities; and no other physiological reasons 
for seizure-like events. 
Alexithymia. The Toronto Alexithymia Scale (TAS-20; Bagby, Taylor, & Parker, 
1994) is the most commonly used measure of alexithymia. It is a self-report measure 
consisting of 20 items, with responses given on a Likert scale ranging from one (strongly 
disagree) to five (strongly agree). The TAS-20 assesses three distinct factors of 
alexithymia, which correspond to the three subscales: Difficulty Identifying Feelings 
(DIF), Difficulty Describing Feelings (DDF), and Externally-Oriented Thinking (EOT). 
The first two factors (DIF and DDF) refer to a poor emotional awareness and the third 
(EOT) refers to a specific tendency to deal with superficial themes and to avoid affective 
thinking. Established cutoff scores indicate that scores less than or equal to 51 indicate 
the absence of alexithymia, scores ranging from 52- 60 indicate possible alexithymia, and 
scores of 61 or greater indicate the presence of alexithymia. In the present study, gender-
normed T-scores, which were computed from total raw scores, were used. Higher scores 
reflect greater alexithymia.  
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 Object naming. The Boston Naming Test (BNT) is a language test that assesses 
visual confrontation object naming (Goodglass and Kaplan, 1983). The test consists of 60 
black and white drawings of common objects of increasing difficulty, ranging from 
simple, high frequency vocabulary words (e.g., comb) to difficult, low frequency words 
(e.g., abacus) (Strauss, Sherman, & Spreen, 2006). The total score is the sum of the 
number of spontaneously produced correct responses, the number of cues given, and the 
number of correct responses given after semantic or phonemic cueing. Age-adjusted T-
scores were used in this study, with higher scores reflecting better performance. 
 Verbal fluency. To evaluate verbal fluency, or the spontaneous production of 
words, two measures were used: the Controlled Oral Word Association Test (COWAT) 
to assess phonemic fluency, and the Animals test to assess semantic fluency (Benton and 
Hamsher, 1976). For both phonemic and semantic fluency tasks, individuals must orally 
produce as many words as they can during a fixed time period.  
During the COWAT, examinees are asked to give words beginning with a specific 
letter; the most commonly used letters for this task are F, A, and S. The COWAT total 
correct score is the sum of all admissible words for each of the three letters. Inadmissible 
words (e.g., proper names, variations, repetitions) are not counted (Strauss et al., 2006). 
Age-adjusted T-scores were used. Higher scores indicate better performance.  
For the Animals test, examinees are given a category and asked to say as many 
words as they can which fall into the category. The most commonly used category, and 
the one used in the current study, is Animals. The total correct score is the sum of all 
admissible words, including extinct, imaginary, or magic animals. Given names like  
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“Mr. Whiskers” and “Rhonda” are not counted (Strauss et al., 2006). Age-adjusted T-
scores were used, with higher scores reflecting better performance.   
Response inhibition. The Stroop Color-Word Test is a widely-used measure of 
selective attention and cognitive control that assesses a person’s ability to maintain a goal 
in mind and suppress a habitual response in favor of a less familiar one. The test consists 
of three tasks: Word (color words, e.g. red, printed in black ink), Color (X’s printed in 
different colors), and Color-Word (color words printed in incongruous colored ink (e.g., 
the word red printed in blue ink)). The participant must read aloud the color words on the 
first sheet, the colors on the second sheet, and the color of the ink (i.e., not the words) on 
the third sheet, within the time limit of 45 seconds per task. In the latter task, the normal 
tendency to read the words, rather than the color of the ink in which the words are 
printed, elicits a significant slowing in reaction time called the “Stroop effect” or the 
“interference effect.”  The extent of the slowing in reaction time, or interference, provides 
a measure of the ability to inhibit a dominant response tendency. Age-adjusted T-scores 
were used, with higher scores reflecting better performance (Strauss et al., 2006).  
Attention and set-shifting. The Trail Making Test (TMT) is a measure of 
attention, speed, and cognitive flexibility. The test is traditionally administered in two 
parts: first the TMT A, which is assumed to tap lower-level perceptual/motor functions 
and cognitive processing speed, and then the TMT B, which is assumed to measure 
cognitive flexibility and set-shifting. Part A requires the subject to connect, by making 
pencil lines, 25 encircled numbers randomly arranged on a page in proper ascending 
order (i.e., 1, 2, 3, etc.). In Part B, the subject is instructed to connect 25 encircled 
numbers and letters in alternating order (i.e., 1, A, 2, B, etc.). TMT scoring is based on 
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the time in seconds required for completion of each of the two parts of the test 
individually. For the purposes of this study, only TMT B scores were considered in the 
analysis. Age-adjusted T-scores were used, with higher scores reflecting better 
performance.  
Data Analysis   
 Descriptive statistics were examined for normality and outliers. Independent 
samples t-tests were conducted to determine if there was a significant difference between 
diagnostic groups on severity of alexithymia and on neuropsychological performance. 
Correlational analyses were conducted within each diagnostic group to examine the 
relationship between scores on TAS-20, BNT, COWAT, Animals, Stroop Interference, 
and TMT B (correlations are provided in Table 3 and Table 4). A moderation analysis 
conducted in SPSS 23.0 was used to assess whether the relationship between 
neuropsychological domains (i.e., verbal/language and executive function) and TAS-20 
Total scores varied as a function of diagnosis. To further discern the specific effects of 
neuropsychological measures on alexithymia within each diagnostic group, multiple 
regression analyses were conducted.   
Results 
Preliminary Analyses 
To compare differences on alexithymia scores and neuropsychological 
performance across diagnostic groups, a series of independent samples t-tests were 
performed (Table 2). PNES patients scored significantly higher than epileptic patients on 
overall alexithymia (TAS Total) and the Difficulty Identifying Feelings (DIF) subscale. 
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Epileptic patients performed significantly worse than PNES patients on the BNT, while 
PNES patients had significantly lower scores on the Stroop Color-Word Interference.  
Table 2  
Means, Standard Deviations, and Differences for PNES and Epilepsy 
  Epilepsy PNES     
Measure Mean SD Mean SD t pdiff 
aTAS Total 52.87 11.07 55.37 11.54 -1.96 0.051 
aTAS 1 DIF 55.52 13.18 59.42 12.84 -2.66 0.008 
aTAS 2 DDF 49.52 11.43 51.92 11.21 -1.88 0.061 
aTAS 3 EOT 51.25 9.67 50.6 10.35 0.57 0.568 
bBNT 37.29 16.82 41.05 13.45 -2.18 0.03 
cCOWAT 44.33 11.45 43.54 11.16 0.615 0.539 
dAnimals 42.06 11.59 44 10.64 -1.53 0.127 
eStroop Word 41.27 10.32 39.81 9.96 1.25 0.213 
fStroop Color 41.8 9.95 39.87 10.41 1.64 0.103 
fStroop 
Interference 
47.09 11.4 42.47 9.8 3.73 < .001 
gTMT A 44.02 14.03 46.03 13.17 -1.31 0.193 
hTMT B 53.25 15.99 44.01 15.14 -0.99 0.322 
Note. pdiff = significance (two-tailed) of the difference in means for 
each measure. aEpilepsy n = 161, PNES n = 154; bEpilepsy n = 161, 
PNES n = 153; cEpilepsy n = 160, PNES n = 151; dEpilepsy n = 
160, PNES n = 150; eEpilepsy n = 154, PNES n = 145; fEpilepsy n 
= 152, PNES n = 144; gEpilepsy n = 159, PNES n = 152; hEpilepsy 
n = 157, PNES n = 152. 
 
Correlations (Table 3 and Table 4) were conducted within each diagnostic group 
to determine the strength of the relationship between TAS scores and neuropsychological 
measures. In epileptic patients TAS-20 Total scores were inversely correlated with 
performance on the BNT, COWAT, and Stroop Interference; while only scores on the 
TMT B were negatively related to TAS-20 scores in PNES patients.  
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Neuropsychological Predictors of Alexithymia Moderated by Diagnosis 
 Diagnostic group was examined as a moderator (Figure 1; Table 5) of the 
relationship between neuropsychological domains (i.e., language/verbal and executive 
function) and alexithymia scores. Two moderation models were used. The first model 
focused on language/verbal ability, and consisted of object naming (BNT) and verbal 
fluency tasks (COWAT & Animals) as predictors of alexithymia, moderated by 
diagnosis. The second model focused on aspects of executive function, namely response 
inhibition (Stroop Interference) and cognitive flexibility (TMT B), as predictors of 
alexithymia, moderated by diagnosis.  
 In the language/verbal model (Figure 2; Table 6), the BNT, the COWAT, and 
Animals were entered in the first step of the regression analysis, diagnosis entered in the 
second step, and interaction terms between diagnosis and each of the three 
language/verbal measures were entered in the third step. Step 1 of the model was 
significant, F(3, 306) = 6.977, p < .001 and accounted for 6.4% of the variance in TAS-
20 scores. Diagnosis was not significant, B = 2.396, p = .059 The three interaction terms 
were not significant: BNT x Diagnosis (B = .035, t(302) = .386, p = .700), COWAT x 
Diagnosis (B = .238, t(302) = 1.789, p = .075), and Animals x Diagnosis (B = - .113, 
t(302) = - .839, p = .402).  
 In the executive function model (Figure 3; Table 7), Stroop Interference and TMT 
B were entered in the first step of the regression analysis, diagnosis in the second step, 
and the interactions between diagnosis and each of the two executive function measures 
were entered in the third step. Step 1 of the model was significant, F(3, 292) = 4.786, p = 
.003 and accounted for 3.8% of the variance in TAS-20 scores. Diagnosis was not 
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significant, B = 2.211, p = .106 The interaction terms, Stroop Interference x Diagnosis (B 
= .029, t(289) = .212, p = .832) and TMT B x Diagnosis (B = -.066, t(289) = - .720, p = 
.472), were not significant. 
 To compare the effects of verbal fluency and executive function on alexithymia, a 
moderation analysis was conducted with one verbal fluency and one executive function 
measure as predictors of alexithymia (using the relatively strongest predictor, 
respectively, from each of the above regressions), and diagnosis as a moderator. The 
COWAT and Stroop Interference were selected to be entered in the first step, diagnosis in 
the second, and the interaction between diagnosis and each of the two neuropsychological 
measures was entered in the third step. Step 1 of the model was significant, F(2, 294) = 
11.63, p < .001, and accounted for 7.3% of the variance in TAS-20 scores. Diagnosis 
again was not significant, B = 2.054, p = .118. Neither of the interaction terms were 
significant: COWAT x Diagnosis (B = .190, t(295) = 1.605, p = .109) and Stroop 
Interference (B = - .059, t(295) = - .458, p = .647).  
 While diagnosis did not moderate the relationship between neuropsychological 
measures and alexithymia, to test the specific hypothesis based on theoretical grounds 
that the etiology of alexithymia results from separable deficits within each diagnosis, 
multiple regression models were run to examine the potential differences in predictors for 
each diagnostic group.  
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Figure 1  
Language/Verbal Moderation Model 
 
Table 5  
Language/Verbal Moderation Model 
  Predictor β p R² ∆R² Sig. F ∆ 
Step 1      
 BNT -.053 .23 .064 - - 
 COWAT -.240 < .001 .064 - - 
 Animals .039 .562 .064 - - 
Step 2      
 Diagnosis 2.396 .059 .075 .011 .059 
Step 3      
 BNT x Dx .035 .700 .087 .012 .283 
 COWAT x Dx .238 .075 .087 .012 .283 
  Animals x Dx -.113 .402 .087 .012 .283 
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Figure 2 
Executive Function Moderation Model
 
Table 6  
Executive Function Moderation Model 
  Predictor β p R² ∆R² Sig. F ∆ 
Step 1      
 Stroop Interference -.174 .009 .038 - - 
 TMT B -.044 .336 .038 - - 
Step 2      
 Diagnosis 2.211 .106 .037 .009 .106 
Step 3      
 Stroop Int x Dx .029 .832 .049 .002 .768 
  TMT B x Dx -.066 .472 .049 .002 .768 
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Figure 3  
Verbal Fluency and Executive Function Moderation Model 
 
Table 7  
Verbal Fluency and Executive Function Moderation Model 
  Predictor β p R² ∆R² Sig. F ∆ 
Step 1      
 COWAT -.207 .001 .073 - - 
 Stroop Interference -.134 .032 .073 - - 
Step 2      
 Diagnosis 2.054 .118 .081 .008 .118 
Step 3      
 COWAT x Dx .190 .109 .089 .008 .277 
  Stroop Int x Dx -.059 .647 .089 .008 .277 
 
Neuropsychological Predictors of Alexithymia in Epilepsy 
  A multiple regression model including the COWAT, BNT, and Animals test as 
predictors of alexithymia for patients with epilepsy accounted for roughly 13% of the 
variance in TAS Total scores, F(3, 157) = 7.745, p < .001 (Table 8). The COWAT was 
the only significant predictor of alexithymia when controlling for the BNT and Animals, 
B = - .346, t(157) = - 3.92, p < .001. Since the three TAS subscales are believed to assess 
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different alexithymic characteristics, and may be related to neuropsychological 
functionality differently, multiple regression analyses were used to examine the effects of 
the neuropsychological variables on each of the subscales. The language/verbal ability 
model accounted for 6% of the variance in the Difficulty Identifying Feelings (DIF) 
subscale (R2 = .06, F(3, 157) = 3.363, p = .02), approximately 7% for the Difficulty 
Describing Feelings (DDF) subscale (R2 = .067, F(3, 157) = 3.627, p = .014), and 15% 
for the Externally Oriented Thinking (EOT) subscale (R2 = .150, F(3, 157) = 9.254, p < 
.001). For all three of the TAS subscales, the COWAT was the only significant predictor 
when controlling for scores on the BNT and Animals; DIF (B = - .267, t(157) = - 2.448, p 
= .015), DDF (B = - .244, t(157) = - 2.58, p = .011), and EOT (B = - .338, t(158) = - 
4.431, p < .001).  
 A multiple regression model including the Stroop Interference and TMT B as 
predictors of alexithymia did not explain a significant amount of variance in TAS Total, 
R2 = .033, F(3, 158) = 2.711, p = .07. However, Stroop Interference was a marginally 
significant predictor of TAS Total scores, B = - .168, t(158) = - 1.924, p = .056. 
Additionally, the Stroop Interference and TMT B accounted for 4.3% of the DDF 
subscale, R2 = .043, F(3, 158) = 3.534, p = .032, but neither variable was a significant 
predictor individually. The executive function model did not account for a significant 
proportion of variance in either DIF or EOT, and there were not any significant 
individual predictors.  
Neuropsychological Predictors of Alexithymia in PNES 
 A multiple regression model (Table 9) including the COWAT, BNT, and Animals 
test as predictors of alexithymia for patients with PNES did not account for a significant 
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proportion of variance in TAS Total (p = .358), DIF (p = .946), or DDF (p = .609); it did, 
however, significantly account for 6.1% of the variance in the EOT subscale, R2 = 
.061, F(3, 150) = 3.223, p = .024. The COWAT performance was the only significant 
predictor of EOT when controlling for scores on the BNT and Animals, B = - .232, t(150) 
= - 2.652, p = .009.  
 A multiple regression model including the Stroop Interference and TMT B as 
predictors of alexithymia did not account for a significant proportion of variance for TAS 
Total (p = .064), DIF (p = .473), or EOT (p = .103). Together, Stroop Interference and 
TMT B accounted for 4.2% of the variance in DDF, R2 = .042, F(2, 151) = 3.344, p = 
.038. Stroop Interference and TMT B performance did not significantly predict scores on 
TAS Total, DIF, DDF, or EOT.  
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Table 8  
Multiple Regression Results for Epilepsy 
Outcome Predictor B SE B Β P 
TAS Total      
 BNT -0.051 0.055 -0.078 0.353 
 COWAT -0.346 0.088 -0.357 < .001 
 Animals 0.071 0.087 0.074 0.413 
 Stroop Interference -0.168 0.088 -0.168 0.056 
 TMT B -0.019 0.061 -0.027 0.759 
TAS 1: DIF      
 BNT -0.078 0.068 -0.1 0.252 
 COWAT -0.267 0.109 -0.231 0.015 
 Animals 0.11 0.107 0.096 0.307 
 Stroop Interference -0.126 0.105 -0.106 0.232 
 TMT B -0.008 0.074 -0.009 0.915 
TAS 2: DDF      
 BNT -0.005 0.059 -0.008 0.928 
 COWAT -0.244 0.094 -0.243 0.011 
 Animals -0.014 0.093 -0.014 0.88 
 Stroop Interference -0.153 0.09 -0.148 0.091 
 TMT B -0.067 0.063 -0.092 0.291 
TAS 3: EOT      
 BNT -0.038 0.048 -0.066 0.424 
 COWAT -0.338 0.076 -0.398 < .001 
 Animals 0.074 0.075 0.089 0.323 
 Stroop Interference -0.133 0.077 -0.153 0.085 
  TMT B 0.012 0.054 0.02 0.82 
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Table 9  
Multiple Regression Results for PNES 
Outcome Predictor B SE B β P 
TAS Total     
 BNT -0.031 0.072 -0.036 0.665 
 COWAT -0.126 0.1 -0.121 0.208 
 Animals -0.022 0.104 -0.02 0.836 
 Stroop Interference -0.129 0.104 -0.107 0.215 
 TMT B -0.094 0.066 -0.123 0.153 
TAS 1: DIF     
 BNT -0.013 0.081 -0.014 0.871 
 COWAT 0.001 0.112 0.001 0.995 
 Animals -0.055 0.117 -0.045 0.638 
 Stroop Interference -0.103 0.117 -0.077 0.379 
 TMT B -0.036 0.074 -0.042 0.632 
TAS 2: DDF     
 BNT -0.001 0.07 -0.001 0.989 
 COWAT -0.09 0.097 -0.088 0.358 
 Animals -0.036 0.102 -0.033 0.727 
 Stroop Interference -0.144 0.101 -0.122 0.155 
 TMT B -0.095 0.064 -0.128 0.135 
TAS 3: EOT     
 BNT -0.041 0.063 -0.053 0.522 
 COWAT -0.232 0.088 -0.248 0.009 
 Animals 0.042 0.092 0.042 0.649 
 Stroop Interference -0.091 0.093 -0.083 0.333 
  TMT B -0.085 0.059 -0.124 0.152 
 
Discussion 
The current study was conducted as an attempt to explain how alexithymia is 
influenced by neuropsychological processes in epilepsy and PNES. It was initially 
proposed that PNES patients would score higher on the TAS-20. It was also hypothesized 
that diagnosis would moderate the relationship between alexithymia and verbal and 
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executive function measures. Furthermore, it was expected that verbal measures would be 
more predictive of alexithymia in epilepsy, and executive function measures to be more 
predictive of alexithymia in PNES. These hypotheses were partially supported.  
As anticipated, PNES patients scored significantly higher on the TAS-20 Total 
and subscale 1 (DIF), while there was no significant difference between diagnostic 
groups for scores on the TAS-20 subscale 2 (DDF) or TAS-20 subscale 3 (EOT). This is 
consistent with the fact that alexithymia was originally proposed to explain 
characteristics of psychosomatic disorders, and PNES patients commonly present high 
rates of somatization (for a review see Baslet, 2011). Results indicated that epileptic 
patients performed worse on an object naming task (BNT), while PNES patients 
performed worse on the response inhibition task (Stroop interference). TAS-20 Total 
scores were inversely related to object naming, phonemic verbal fluency, and response 
inhibition in epilepsy, and set-shifting in PNES.  
Interestingly, despite that there were no significant differences between diagnostic 
groups in phonemic fluency (COWAT) scores, the COWAT was only a significant 
predictor of alexithymia in epilepsy, and not in PNES. One possible explanation could be 
that language impairment often is associated with temporal lobe epilepsy, predominantly 
within the language dominant hemisphere (Fargo et al., 2005), whereas deficits in verbal 
fluency in PNES may stem from other processes (e.g., deficits in executive function, 
depression) but do not reflect the kinds of language-related issues that characterize 
alexithymia.   
Contrary to hypotheses, diagnosis did not moderate the relationship between both 
verbal or executive function performance and alexithymia. Nevertheless, subsequent 
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multiple regression analysis within each diagnostic category revealed that, as 
hypothesized, epileptic patients’ performance on the COWAT significantly predicted 
Total TAS-20 scores. Contrary to expectations, however, a measure of executive 
function, Stroop interference, was a marginally significant predictor of TAS-20 Total 
scores in epileptic patients, but was not significant among PNES patients. Exploratory 
analyses were conducted by diagnostic group to further explore the impact of each 
neuropsychological measure on specific subscales characteristic of components of 
alexithymia. Epileptic patients’ phonemic verbal fluency abilities significantly predicted 
their difficulty identifying feelings, difficulty describing feelings, and the extent to which 
they focus on externally oriented stimuli rather than interoceptive stimuli. PNES patients’ 
phonemic verbal fluency abilities significantly predicted their preoccupation with 
external, rather than internal, stimuli.  
The COWAT and Stroop interference were both significant predictors of 
alexithymia, despite only accounting for a small portion of variance in epileptic patients. 
The COWAT assesses the ability to spontaneously produce phonemically similar words, 
while the Stroop interference trial evaluates the ability to suppress, or regulate, initial 
response tendencies to stimuli (Strauss et al., 2006). Moreover, Golden (1972) postulated 
that in addition to assessing response inhibition, the Stroop test also assesses an 
individual’s ability to cope with cognitive stress and process complex input. Thus, 
decreased performance on these tasks may provide insight into which epileptic patients 
are at risk for greater potential dysfunctional affective processes due to deficient 
communication capabilities and/or maladaptive emotion regulation techniques, which in 
turn may pose challenges in patients’ reactions and responses to daily life stressors.  
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One possible explanation for why diagnostic group did not moderate the 
relationship between neuropsychological performance and alexithymia could be the 
notable lack of significant group performance differences across the different cognitive 
tasks. The results may also be attributable to a non-significant difference in the 
proportion of patients (i.e., 27.3% epilepsy; 35.1% PNES; p = .136) who met the 
alexithymic criteria (TAS-20 Total scores ≥ 61). Epileptic and PNES patients both scored 
lower on the COWAT and Stroop Interference, respectfully, relative to valid and reliable 
established norms (for review see Strauss et al., 2006). There is an interesting theoretical 
relationship, however, regarding the underlying neural circuitry involved during 
COWAT, Stroop tasks, and alexithymia. In general, neuroimaging studies have 
demonstrated increased activation in the dorsolateral prefrontal cortex (dlPFC) and ACC 
during phonemic verbal fluency tasks and the Stroop test (for review see Alvarez et al., 
2006; Bush, Luu, & Posner, 2000). Conversely, decreased functional connectivity has 
been observed in the same neural regions in alexithymic individuals (Lane et al., 1997; 
Moriguchi et al., 2013). This is consistent with Lane et al.’s (1997) ‘blindfeel’ hypothesis 
that theorized the conscious experience of emotions is compromised in alexithymia, due 
to the loss of fibers between the ACC and affect-generating brain regions. This is 
congruent with the literature on the multitude of functions associated with ACC 
activation, including attention and interference (Bush, Luu, & Posner, 2000), evaluating 
and processing the emotional meaning of stimuli (Etkin, Egner, & Kalisch, 2011), as well 
as during the cognitive control of emotion regulation (Urry, Van Reekum, Johnstone, & 
Davidson, 2009).  
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Limitations 
This study posed several limitations; an important one was the use of a single 
alexithymia measure. Even while the TAS-20 is the most widely used tool to assess 
alexithymia, it is not a perfect measure. Many studies have criticized the reliability of the 
third TAS subscale, EOT (Kooiman et al., 2002; Müller, Bühner, & Ellgring, 2003), and 
some argue that alexithymia may comprise of an affective and cognitive dimension 
(Vorst & Bermond, 2001) and the TAS-20 only taps into the cognitive dimension of 
alexithymia (Koven et al., 2011). Lane et al. (2015) raised an important question 
regarding the nature of a fundamental tenet of alexithymia. Specifically, there is a 
question of whether the difficulty identifying and describing one’s feelings is a result of 
individuals knowing what they feel but being unable to convey it properly, or not 
knowing what they are feeling, which is why they have difficulty describing it (Lane et 
al., 2015). Another important limitation was the comparatively small number of patients 
diagnosed with right or left temporal lobe epilepsy. This did not allow us to directly 
assess how seizure localization could influence alexithymia and its relationship to 
neuropsychological performance. A further limitation regards the lack of a healthy, non-
clinical control group to use to compare the diagnostic groups on performance on all 
measures.  
Conclusion 
To our knowledge, this was the first study to examine alexithymia as it pertains to 
neuropsychological functioning within these two diagnostic groups. Future studies should 
focus on other potential deficient cognitive aspects that may underlie the manifestation of 
alexithymia. Taken together, the results of this study provide evidence that alexithymia is 
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related to neuropsychological functioning deficits in individuals with PNES and epilepsy. 
Roughly a third of both epileptic and nonepileptic patients in our sample met the clinical 
criteria for alexithymia, indicating that one out of every three of our patients diagnosed at 
the EMU experiences a severe limitation in their affective capacity (i.e., emotional 
awareness, processing, and regulation). The consequential nature of this diminished 
affective capacity is cyclical and can spread to all facets of their lives, further 
perpetuating the likelihood and severity of various health-related problems, interpersonal 
difficulties, and a drastic reduction in perceived quality of life. Hence, intervention 
targeted specifically towards lessening the negative impact of alexithymia and improving 
dysfunctional affective tendencies and behavioral patterns, should be a priority.  
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